肠道菌群
疾病
寄主(生物学)
炎症
医学
人类健康
个性化医疗
全身炎症
人类疾病
免疫学
生物信息学
生物
生态学
环境卫生
内科学
作者
Payam Behzadi,Verónica I. Dodero,Olga Golubnitschaja
出处
期刊:Advances in predictive, preventive and personalised medicine
日期:2024-01-01
卷期号:: 203-241
被引量:12
标识
DOI:10.1007/978-3-031-46891-9_15
摘要
The level of synergies between the human host and gut microbiota is frequently underestimated: growing evidence demonstrates a multi-faceted interplay influencing health status stability of the host, health-to-disease transition, disease severity grad, therapy-resistance and individual outcomes. Moreover, a powerful instrument has been established in cross-talk between the human host and gut microbiota, namely an inflammation. Therefore, a detailed understanding of mechanisms underlying systemic inflammation as the key-tool to regulate the quality and stability of cooperation between the human host and gut microbiota is crucial for cost-effective screening programs and targeted disease prevention in primary and secondary care following the principles of 3P Medicine.
科研通智能强力驱动
Strongly Powered by AbleSci AI